\n\n\n \n \n\n \n \n \n \n\n\n \n\n \n\n Nov 18, 2009 7:00 AM EST
\n\n \n Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 12, 2009 4:22 PM EST
\n\n \n Tekmira Pharmaceuticals Corporation Announces Third Quarter 2009 Operating Results and Provides Corporate Update - Marketwire Canada\n \n \n | \n\n \n\n \n\n \n\n Nov 12, 2009 7:00 AM EST
\n\n \n Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 09, 2009 9:27 AM EST
\n\n \n Alnylam to Webcast R&D Day on Thursday, November 12, 2009 - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 05, 2009 7:00 AM EST
\n\n \n Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 04, 2009 4:00 PM EST
\n\n \n Alnylam Pharmaceuticals Reports Third Quarter 2009 Financial Results - Business Wire\n \n \n | \n\n \n\n \n\n \n\n Nov 03, 2009 7:00 AM EST
\n\n \n Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference - PR Newswire\n \n \n | \n\n \n\n \n | \n
\n\n
\n\n");